Cas:173435-34-2 2-Chloro-4-methoxy-3-pyridinamine manufacturer & supplier

We serve Chemical Name:2-Chloro-4-methoxy-3-pyridinamine CAS:173435-34-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Chloro-4-methoxy-3-pyridinamine

Chemical Name:2-Chloro-4-methoxy-3-pyridinamine
CAS.NO:173435-34-2
Synonyms:2-Chloro-4-methoxy-pyridin-3-ylamine;2-Chloro-4-methoxy-3-pyridinamine;3-amino-2-chloro-4 methoxypyridine;TPC-PY002;3-Pyridinamine, 2-chloro-4-methoxy-;2-Chloro-4-methoxypyridin-3-amine;FD7393
Molecular Formula:C6H7ClN2O
Molecular Weight:158.586
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:288.6±35.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.579
PSA:48.14000
Exact Mass:158.024689
LogP:1.78

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Chloro-4-methoxy-pyridin-3-ylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,FD7393 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,FD7393 Use and application,2-Chloro-4-methoxy-pyridin-3-ylamine technical grade,usp/ep/jp grade.


Related News: A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. 2-Chloro-4-methoxy-3-pyridinamine manufacturer In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. 2-Chloro-4-methoxy-3-pyridinamine supplier As a result, the Company��s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy. 2-Chloro-4-methoxy-3-pyridinamine vendor This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire. 2-Chloro-4-methoxy-3-pyridinamine factory In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks.